Reckitt Benckiser Group ( LON:RKT ) Full Year 2024 Results Key Financial Results Revenue: UK£14.2b (down 3.0% from FY... LONDON (Reuters) -Britain's Reckitt Benckiser, the maker of Strepsils throat ...
February 25, 2025 UK's Reckitt shortlists bidders for $6 billion homecare portfolio, Bloomberg reports Reckitt Benckiser has shortlisted private equity firms Lone Star Funds, Advent and Apollo ...
Key Insights Reckitt Benckiser Group's estimated fair value is UK£81.40 based on 2 Stage Free Cash Flow to Equity... The new facility will help to boost Reckitt's production of Mucinex cold and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback